An Extensive Application for All Targeted Therapy Options
Comprehensively covers biomarkers included in drug labels, clinical guidelines, and ongoing clinical trials, supporting more informed and personalized treatment decisions.
Detects SNVs, indels, CNVs, TMB, HRD, and MSI — delivering a complete molecular picture to inform personalized treatment.
An all-in-one genomic testing solution for immunotherapy and targeted therapy, fully validated in solid tumor
Key Features and Benefits
Performance Validations

Note: Different mutation types demonstrated a consistent >97% sensitvity and >95% specificity in clinical sample validation tests.




Clinical Trial Studies



OncoCompass® Plus was utilized as the designated NGS assay in China for a multi-regional clinical trial (MRCT) in the HR+ advanced breast cancer, in which another NGS platform was used in other regions. Its inclusion reflects the assay’s analytical robustness and alignment with global clinical trial standards.


Contact Our Biopharma Team to Learn More
Biomarker Discovery & Translational Research
Clinical Trial Design & Patient Recruitment
Global Capabilities for Clinical Studies
CDx Development & Commercialization
Genomic Data Solutions
ctDNA Monitoring Portfolio
Other
I also want to receive general marketing communications from Burning Rock Dx in addition to the specific information requested here. You may unsubscribe from receiving such general marketing communications at any time.
*Required
By submitting this form, or by checking the box above the “Submit” button (if applicable), you agree that your information will be processed according to Burning Rock’s privacy policy to provide you with the information and/or general marketing communications (if applicable) you have requested here. Burning Rock Dx is committed to protecting and respecting your privacy.
Contact Our Experts
We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."